Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Elite Pharmaceuticals Announces FDA Approval of Supplemental Application for Naltrexone
Feb. 7, 2013
Elite Pharmaceuticals announced on Jan. 31, 2012, the FDA approved the company’s supplemental application for the manufacturing and packaging of naltrexone hydrochloride 50 mg tablets.
Yahoo! Medical News
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing